Skip Ribbon Commands
Skip to main content
Menu
Prof Tay Sun Kuie

Prof Tay Sun Kuie

​MBBS, FRCOG (UK), MD (Lond), FAMS, MAppLaw

Senior Consultant

Singapore General Hospital

Specialty/Department: Surgery & Surgical Oncology, Obstetrics & Gynaecology

Clinical Interest: Obstetrics & Gynaecology, Endometriosis

Conditions Treated by this Doctor:
Cervical Cancer, Ovarian Cancer, Vaginal Cancer, Vulva Cancer.

Clinical Appointments

  • Senior Consultant Obstetrics & Gynaecology Singapore General HospitalSingapore General Hospital
  • Senior Consultant Division of Surgery & Surgical Oncology National Cancer Centre SingaporeNational Cancer Centre Singapore

Academic Appointments

  • Duke-NUS Medical School
  • NUS Yong Loo Lin School of Medicine

Profile

Professor Tay is a senior consultant Obstetrician and gynecologist providing a full range of gynaecological services encompassing conventional and minimally invasive surgeries, with special interestsView More +

Education

  • MBBS
  • FRCOG (UK)
  • MD (Lond)
  • FAMS
  • MAppLaw

Professional Appointments and Committee Memberships

  • Senior Consultant Obstetrician & Gynaecologist, Singapore General Hospital
  • Visiting Senior Consultant, National Cancer Centre Singapore
  • Clinical Associate Professor, Yong Loo Lin School of Medicine, National University of Singapore
  • Clinical Professor, Duke-NUS Medical School
  • Member, Complaints Committee, Singapore Medical Council
  • Principal Mediator, Singapore Mediation Centre
  • Volunteer Mediator, State Courts, Singapore
View More +

Awards

  • Hamilton & Bailey Prize in Surgery 1987 
  • National Science Award 1996
  • 16th Benjamin Sheares Memorial Lectureship 1997
  • Excellent Publication Award 1999
  • Review with Distinction Award, Singapore Medical Journal, 2005. 2006, 2008

Research Interests

Publications

  1. Tay SK, Hsu TY, Pavelyev A, Walia A, Kulkarni AS. Clinical and economic impact of school-based nonavalent human papillomavirus vaccine on women in Singapore: a transmission dynamic mathematical model analysis. BJOG. 2018 Mar;125(4):478-486. doi: 10.1111/1471-0528.15106. PMID: 29266694.
  2. Tay SK, Lee BW, Sohn WY, Lee IH, Mathur G, Sanicas M, Van Kriekinge G. Cost-effectiveness of two-dose human papillomavirus vaccination in Singapore. Singapore Med J. 2018 Jul;59(7):370-382. doi: 10.11622/smedj.2017085. Epub 2017 Oct 6. PMID: 28983579; PMCID: PMC6056373.
  3. Tay SK, Hsu TY, Shcheprov A, Walia A, Kulkarni AS. The clinical and economic benefits of school-based quadrivalent HPV vaccination in Singapore. Int J Gynaecol Obstet. 2017 May;137(2):129-137. doi: 10.1002/ijgo.12126. Epub 2017 Mar 10. PMID: 28190260.
  4. Tay SK, Lin LE, Goh RC. Detection Rate of High-Grade Cervical Neoplasia and Cost-Effectiveness of High-Risk Human Papillomavirus Genotyping with Reflex Liquid-based Cytology in Cervical Cancer Screening. Ann Acad Med Singap. 2017 Jul;46(7):267-273. PMID: 28821890.
  5. Tay K, Tay SK, Tesalona KC, Rashid NM, Tai EY, Najib SJ. Factors affecting the uptake of cervical cancer screening among nurses in Singapore. Int J Gynaecol Obstet. 2015 Sep;130(3):230-4. doi: 10.1016/j.ijgo.2015.03.037. Epub 2015 May 23. PMID: 26032624.
  6. Nin DS, Yew CW, Tay SK, Deng LW. Targeted silencing of MLL5β inhibits tumor growth and promotes gamma-irradiation sensitization in HPV16/18-associated cervical cancers. Mol Cancer Ther. 2014 Nov;13(11):2572-82. doi: 10.1158/1535-7163.MCT-14-0019. Epub 2014 Aug 29. PMID: 25172963.
  7. Tay SK, Cheong MA. Evidence for ethnic and environmental contributions to frequency of ovarian clear cell carcinoma. Aust N Z J Obstet Gynaecol. 2014 Jun;54(3):225-30. doi: 10.1111/ajo.12188. Epub 2014 Feb 19. PMID: 24888594.
  8. Tay SK, Oon LL. Prevalence of cervical human papillomavirus infection in healthy women is related to sexual behaviours and educational level: a cross-sectional study. Int J STD AIDS. 2014 Dec;25(14):1013-21. doi: 10.1177/0956462414528315. Epub 2014 Mar 19. PMID: 24648316.
  9. Chay WY, Chew SH, Ong WS, Busmanis I, Li X, Thung S, Ngo L, Lim SL, Lim YK, Chia YN, Koh E, Pang C, Soh LT, Wang J, Ho TH, Tay SK, Lim-Tan SK, Lim KH, Chia JW, Goh LK. HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer. PLoS One. 2013 Apr 19;8(4):e61565. doi: 10.1371/journal.pone.0061565. PMID: 23620766; PMCID: PMC3631219.
  10. Tay SK. Cervical cancer in the human papillomavirus vaccination era. Curr Opin Obstet Gynecol. 2012 Feb;24(1):3-7. doi: 10.1097/GCO.0b013e32834daed9. PMID: 22123221.
  11. Tan PS, Koh E, Pang C, Ong WS, Ngo L, Soh LT, Quek R, Chay WY, Ho TH, Tay SK, Chew SH, Lim-Tan SK, Khoo-Tan H, Lim SL, Busmanis I, Goh LK, Chia YN, Chia WK, Lim T. Uterine leiomyosarcoma in asian patients: validation of the revised Federation of gynecology and obstetrics staging system and identification of prognostic classifiers. Oncologist. 2012;17(10):1286-93. doi: 10.1634/theoncologist.2012-0124. Epub 2012 Jul 24. PMID: 22829569; PMCID: PMC3481894.
  12. Lee VJ, Tay SK, Teoh YL, Tok MY. Cost-effectiveness of different human papillomavirus vaccines in Singapore. BMC Public Health. 2011 Mar 31;11:203. doi: 10.1186/1471-2458-11-203. PMID: 21453537; PMCID: PMC3082243.
  13. Tay K, Tay SK. The impact of cytology screening and HPV vaccination on the burden of cervical cancer. Asia Pac J Clin Oncol. 2011 Jun;7(2):154-9. doi: 10.1111/j.1743-7563.2011.01396.x. PMID: 21585695.
  14. Yew CW, Lee P, Chan WK, Lim VK, Tay SK, Tan TM, Deng LW. A novel MLL5 isoform that is essential to activate E6 and E7 transcription in HPV16/18-associated cervical cancers. Cancer Res. 2011 Nov 1;71(21):6696-707. doi: 10.1158/0008-5472.CAN-11-1271. Epub 2011 Sep 9. PMID: 21908553.

Research Trials